Development and Validation of a New High-Performance Liquid Chromatography-Ultraviolet Assay for Quantification of Mitoxantrone in Plasma of BALB/c-nu Mice

被引:0
作者
Tao, Yanru [1 ]
Zhao, Hua [1 ]
Xiang, Yujie [1 ]
Li, Jin [1 ,2 ]
Li, Yanting [1 ]
Hu, Jiangling [1 ]
Wang, Hongmei [1 ,3 ]
Jiang, Xinhui [1 ]
机构
[1] Chongqing Med Univ, Chongqing Res Ctr Pharmaceut Engn, Sch Pharm, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Childrens Hosp, Dept Pharm, Chongqing 400014, Peoples R China
[3] Chongqing Lybon Pharm Tech Co Ltd, Fu An Pharmaceut Grp, Anal Dept, Chongqing 401121, Peoples R China
关键词
PHARMACOKINETICS;
D O I
10.1093/chromsci/bmae007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The concentration of mitoxantrone in the blood of mice was determined by a high-performance liquid chromatography-ultraviolet method with aloe-emodin as the internal standard. The separation was performed on a Hypersil BDS2 column (4.6 x 250 mm, 5 mu m) as the analytical column, the mobile Phase A was acetonitrile, and B was 20-mM potassium dihydrogen phosphate (adding 1% triethylamine and adjusting the pH to 2.8 with phosphoric acid) and 4.6-mM sodium octyl sulfonate. The flow rate was 1.0 mL<middle dot>min(-1), the detection wavelength was 243 nm, the column temperature is 25 +/- 5 degrees C and the injection amount was 20 mu L. Finally, the linear range of mitoxantrone was 5-200 mu g<middle dot>mL(-1), and the correlation coefficient was r = 0.9999. The recovery rate of the method was 91.93-105.5%, and the extraction recovery rate was 91.45-105.5%. The intraday precision and interday precision were <3.29% (limit of detection = 0.3 mu g<middle dot>mL(-1)). The HPLC method established in this paper was simple, rapid, sensitive and accurate, and can be used to determine the content of mitoxantrone in mouse plasma after tail vein injection.
引用
收藏
页数:6
相关论文
共 21 条
[1]   HPLC analysis of mitoxantrone in mouse plasma and tissues: Application in a pharmacokinetic study [J].
An, Guohua ;
Morris, Marilyn E. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 51 (03) :750-753
[2]  
[Anonymous], 2018, Bioanalytical method validation guidance for industry
[3]  
BLANZ J, 1991, DRUG METAB DISPOS, V19, P871
[4]  
Cao Y.X., 2021, China Medical Innovation, V18, P125, DOI [10.3969/j.issn.1674-4985.2021.05.032, DOI 10.3969/J.ISSN.1674-4985.2021.05.032]
[5]  
Chen S.B., 2021, Journal of Peking Union Medical College, V12, P729
[6]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR MITOXANTRONE IN PLASMA USING ELECTROCHEMICAL DETECTION [J].
CHOI, KE ;
SINKULE, JA ;
HAN, DS ;
MCGRATH, SC ;
DALY, KM ;
LARSON, RA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 420 (01) :81-88
[7]  
EHNINGER G, 1985, INVEST NEW DRUG, V3, P109
[8]  
Ficarra R., 1993, Bollettino Chimico Farmaceutico, V131, P419
[9]  
GUO P, 1991, Yaoxue Xuebao, V26, P367
[10]   Improved liquid chromatographic method for mitoxantrone quantification in mouse plasma and tissues to study the pharmacokinetics of a liposome entrapped mitoxantrone formulation [J].
Johnson, JL ;
Ahmad, A ;
Khan, S ;
Wang, YF ;
Abu-Qare, AW ;
Ayoub, JE ;
Zhang, A ;
Ahmad, I .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 799 (01) :149-155